28 | Dexamethasone (Maxidex)FDA LinkGeneric
06/2022
-
07/2010 |
24 | Bortezomib (Velcade)FDA Link
01/2022
-
04/2006 |
19 | Lenalidomide (CC 5013)FDA Link
06/2022
-
08/2010 |
13 | daratumumabIBA
01/2022
-
01/2017 |
7 | venetoclaxIBA
11/2021
-
11/2017 |
7 | Proteasome InhibitorsIBA
01/2019
-
03/2007 |
6 | Monoclonal AntibodiesIBA
12/2020
-
01/2006 |
6 | Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2018
-
06/2009 |
5 | Proteins (Proteins, Gene)FDA Link
01/2022
-
08/2011 |
5 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020
-
04/2012 |
5 | plerixaforFDA Link
01/2018
-
06/2009 |
5 | Rituximab (Mabthera)FDA Link
11/2015
-
04/2012 |
4 | carfilzomibIBA
10/2021
-
06/2012 |
3 | elotuzumabIBA
06/2022
-
06/2012 |
3 | Immunoglobulins (Immunoglobulin)IBA
02/2022
-
08/2013 |
3 | filanesibIBA
01/2022
-
11/2016 |
3 | Melphalan (Alkeran)FDA LinkGeneric
01/2022
-
04/2014 |
3 | Biomarkers (Surrogate Marker)IBA
01/2021
-
09/2013 |
3 | Proteasome Endopeptidase Complex (Proteasome)IBA
01/2019
-
04/2006 |
3 | Vincristine (Oncovin)FDA LinkGeneric
11/2015
-
04/2012 |
3 | Doxorubicin (Adriamycin)FDA LinkGeneric
11/2015
-
04/2012 |
2 | KinesinsIBA
01/2022
-
11/2016 |
2 | VorinostatFDA Link
12/2020
-
01/2016 |
2 | Histone Deacetylase InhibitorsIBA
12/2020
-
08/2013 |
2 | Biological ProductsIBA
12/2019
-
01/2013 |
2 | ixazomibIBA
01/2019
-
12/2014 |
2 | PanobinostatIBA
01/2019
-
10/2014 |
2 | Prednisone (Sone)FDA LinkGeneric
11/2015
-
07/2012 |
2 | Pharmaceutical PreparationsIBA
12/2014
-
10/2014 |
1 | VaccinesIBA
10/2022 |
1 | Pregabalin (Lyrica)FDA Link
01/2022 |
1 | Gabapentin (Neurontin)FDA LinkGeneric
01/2022 |
1 | Immunoglobulin M (IgM)IBA
11/2021 |
1 | Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA
01/2021 |
1 | vendexIBA
01/2021 |
1 | isatuximabIBA
12/2020 |
1 | 2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2019 |
1 | PVX-410 vaccineIBA
12/2018 |
1 | pomalidomideIBA
01/2017 |
1 | Immunoglobulin G (IgG)IBA
03/2016 |
1 | CreatinineIBA
03/2016 |
1 | marizomibIBA
01/2016 |
1 | 14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA
01/2016 |
1 | ParaproteinsIBA
03/2015 |
1 | Immunomodulating AgentsIBA
09/2014 |
1 | Fibroblast Growth Factor 7FDA Link
06/2014 |
1 | Busulfan (Busulfex)FDA Link
06/2014 |
1 | Etoposide (VP 16)FDA LinkGeneric
06/2014 |
1 | milatuzumabIBA
11/2013 |
1 | Antineoplastic Agents (Antineoplastics)IBA
08/2013 |